Literature DB >> 1548770

Reversion of Q beta RNA phage mutants by homologous RNA recombination.

K Palasingam1, P N Shaklee.   

Abstract

Q beta phage RNAs with inactivating insertion (8-base) or deletion (17-base) mutations within their replicase genes were prepared from modified Q beta cDNAs and transfected into Escherichia coli spheroplasts containing Q beta replicase provided in trans by a resident plasmid. Replicase-defective (Rep-) Q beta phage produced by these spheroplasts were detected as normal-sized plaques on lawns of cells containing plasmid-derived Q beta replicase, but were unable to form plaques on cells lacking this plasmid. When individual Rep- phage were isolated and grown to high titer in cells containing plasmid-derived Q beta replicase, revertant (Rep+) Q beta phage were obtained at a frequency of ca. 10(-8). To investigate the mechanism of this reversion, a point mutation was placed into the plasmid-derived Q beta replicase gene by site-directed mutagenesis. Q beta mutants amplified on cells containing the resultant plasmid also yielded Rep+ revertants. Genomic RNA was isolated from several of the latter phage revertants and sequenced. Results showed that the original mutation (insertion or deletion) was no longer present in the phage revertants but that the marker mutation placed into the plasmid was now present in the genomic RNAs, indicating that recombination was one mechanism involved in the reversion of the Q beta mutants. Further experiments demonstrated that the 3' noncoding region of the plasmid-derived replicase gene was necessary for the reversion-recombination of the deletion mutant, whereas this region was not required for reversion or recombination of the insertion mutant. Results are discussed in terms of a template-switching model of RNA recombination involving Q beta replicase, the mutant phage genome, and plasmid-derived replicase mRNA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1548770      PMCID: PMC289039     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Recombination between Sindbis virus RNAs.

Authors:  B G Weiss; S Schlesinger
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

Review 2.  Sex and recombination in retroviruses.

Authors:  H M Temin
Journal:  Trends Genet       Date:  1991-03       Impact factor: 11.639

3.  Efficient templates for Q beta replicase are formed by recombination from heterologous sequences.

Authors:  A V Munishkin; L A Voronin; V I Ugarov; L A Bondareva; H V Chetverina; A B Chetverin
Journal:  J Mol Biol       Date:  1991-09-20       Impact factor: 5.469

4.  Similar conformers in the minus strands of divergent positive strand RNA phage.

Authors:  P N Shaklee
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

Review 5.  RNA replication: function and structure of Qbeta-replicase.

Authors:  T Blumenthal; G G Carmichael
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

Review 6.  The making of a phage.

Authors:  C Weissmann
Journal:  FEBS Lett       Date:  1974-03-23       Impact factor: 4.124

7.  Interactions of Q beta replicase with Q beta RNA.

Authors:  F Meyer; H Weber; C Weissmann
Journal:  J Mol Biol       Date:  1981-12-15       Impact factor: 5.469

8.  Nanovariant RNAs: nucleotide sequence and interaction with bacteriophage Qbeta replicase.

Authors:  W Schaffner; K J Rüegg; C Weissmann
Journal:  J Mol Biol       Date:  1977-12-25       Impact factor: 5.469

9.  Interference with viral infection by defective RNA replicase.

Authors:  Y Inokuchi; A Hirashima
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

10.  Random nature of coronavirus RNA recombination in the absence of selection pressure.

Authors:  L R Banner; M M Lai
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

View more
  29 in total

1.  Frequent homologous recombination events between molecules of one RNA component in a multipartite RNA virus.

Authors:  A Bruyere; M Wantroba; S Flasinski; A Dzianott; J J Bujarski
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Genetic recombination in brome mosaic virus: effect of sequence and replication of RNA on accumulation of recombinants.

Authors:  P D Nagy; J J Bujarski
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  Homologous crossovers among molecules of brome mosaic bromovirus RNA1 or RNA2 segments in vivo.

Authors:  Anna Urbanowicz; Magdalena Alejska; Piotr Formanowicz; Jacek Blazewicz; Marek Figlerowicz; Jozef J Bujarski
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Efficient in vitro system of homologous recombination in brome mosaic bromovirus.

Authors:  Rafal Wierzchoslawski; Jozef J Bujarski
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  Nonhomologous RNA recombination during negative-strand synthesis of flock house virus RNA.

Authors:  Y Li; L A Ball
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

6.  Cloning of RNA molecules in vitro.

Authors:  H V Chetverina; A B Chetverin
Journal:  Nucleic Acids Res       Date:  1993-05-25       Impact factor: 16.971

7.  Template-switching during DNA synthesis by Thermus aquaticus DNA polymerase I.

Authors:  S J Odelberg; R B Weiss; A Hata; R White
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

8.  RNA-RNA recombination in Sindbis virus: roles of the 3' conserved motif, poly(A) tail, and nonviral sequences of template RNAs in polymerase recognition and template switching.

Authors:  K R Hill; M Hajjou; J Y Hu; R Raju
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

Review 9.  Emergency Services of Viral RNAs: Repair and Remodeling.

Authors:  Vadim I Agol; Anatoly P Gmyl
Journal:  Microbiol Mol Biol Rev       Date:  2018-03-14       Impact factor: 11.056

10.  Homologous RNA recombination in brome mosaic virus: AU-rich sequences decrease the accuracy of crossovers.

Authors:  P D Nagy; J J Bujarski
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.